Dr. Shelley Zieroth joined the Section of Cardiology at St. Boniface Hospital in Winnipeg in July 2006. She is currently an Associate Professor in the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics. She is also Head of the Medical Heart Failure Program for the Winnipeg Regional Health Authority, Cardiac Sciences Program.
Dr. Zieroth attended medical school at the University of Manitoba and went on to train in Internal Medicine and Cardiology at the same centre. She completed her Postdoctoral Clinical Fellowship, specializing in Advanced Heart Failure and Cardiac Transplant, at Toronto General Hospital.
She is involved in several heart failure clinical trials as a PI, is National Lead for EMPACT-MI, EMPULSE, DETERMINE and FINE-ARTS clinical trials and she is on the Steering Committee of PARAGLIDE. Her area of research examines the efficacy of new treatments including food derived bioactives in heart failure. She is the Immediate Past President of the Canadian Heart Failure Society and on the Canadian Cardiovascular Society Primary Panels for both the Heart Failure and Heart Transplant Guidelines. She is also Co-Chair of Canada's largest annual heart failure meeting, HF Update, and Scientific Planning Committee Chair for the Canadian Cardiovascular Congress. Her current passion is working with national and provincial patient advocacy groups and primary care to operationalize hub and spoke models of heart failure care.
Dr. Zieroth is actively engaged in Social Media and promotes #cardiotwitter for its rapid access to clinical trial data, publications and free on line access to medical education. It is through this engagement Dr. Zieroth has become recognized as a global supporter and sponsor of women in medicine and cardiology.